Vericel Financial Ratios
NASDAQ: VCELHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Vericel ratio analysis
Vericel earned a net margin of 6.0% in FY 2025, up from 4.4% a year earlier. Gross margin was 74.4% compared with a median of 67.8% over the prior 9 years. Return on equity reached 4.7%, meaning Vericel generated 0.05 dollars of profit for every dollar of shareholders' equity.
At the end of FY 2025, VCEL traded at 111.3 times earnings; across the 3 fiscal years shown, its year-end P/E ranged from 111.3 to 514.7, with a median of 287.5. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Vericel financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 111.28 | 287.50 | — | — | — | 514.67 | — | — | — | — |
| Price / sales | 6.49 | 11.84 | 8.58 | 7.55 | 11.69 | 11.25 | 6.44 | 7.66 | 2.84 | 1.27 |
| Price / book | 5.05 | 9.62 | 7.50 | 6.46 | 10.71 | 10.40 | 6.84 | 6.81 | 8.06 | 2.80 |
| Gross margin | 74.4% | 72.6% | 68.6% | 66.8% | 67.9% | 67.8% | 68.1% | 64.6% | 52.5% | 47.9% |
| Operating margin | 4.0% | 1.9% | -3.3% | -10.4% | -5.0% | 1.9% | -9.5% | -4.3% | -23.4% | -35.4% |
| Net margin | 6.0% | 4.4% | -1.6% | -10.2% | -4.8% | 2.3% | -8.2% | -9.0% | -27.0% | -36.0% |
| Free cash flow margin | 9.0% | -2.4% | 7.7% | 6.1% | 13.5% | 12.0% | -8.3% | -3.4% | -23.0% | -39.2% |
| Return on equity (ROE) | 4.7% | 3.5% | -1.4% | -8.7% | -4.4% | 2.1% | -8.7% | -8.0% | -76.7% | -79.2% |
| Return on assets (ROA) | 3.4% | 2.4% | -0.9% | -6.1% | -3.1% | 1.4% | -6.3% | -6.9% | -31.7% | -40.3% |
| Debt / equity | — | — | — | — | — | — | — | — | 0.75 | 0.38 |
| Current ratio | 5.03 | 4.23 | 4.49 | 4.99 | 6.08 | 5.50 | 5.64 | 7.62 | 3.86 | 3.48 |
| Revenue growth | 16.5% | 20.1% | 20.2% | 5.2% | 25.8% | 5.4% | 29.7% | 42.1% | 17.5% | 6.3% |
| EPS growth | 60.0% | — | — | — | -366.7% | — | — | — | — | — |